Please use this identifier to cite or link to this item:
|Title:||Significance of baseline and change in quality of life scores in predicting clinical outcomes in an international phase III trial of advanced pancreatic cancer: NCIC CTG PA.3|
|Authors:||Lee, Chee Khoon|
Au, Heather Jane
Jonker, Derek J.
Moore, Malcolm J.
O'Callaghan, Chris J.
Parulekar, Wendy R.
Vickers, Michael M.
NH&MRC Clinical Trials Centre
|Publisher:||S. Karger AG|
|Citation:||Significance of baseline and change in quality of life scores in predicting clinical outcomes in an international phase III trial of advanced pancreatic cancer: NCIC CTG PA.3, Pancreatology, vol.16, 6, 2016,pp 1106-1112|
|Department/Unit/Centre:||NH&MRC Clinical Trials Centre|
|Disclaimer:||This work has been made available to the staff and students of the University of Sydney for the purposes of research and study only. It constitutes material that is held by the University for the purposes of reporting for HERDC and the ERA. This work may not be downloaded, copied and distributed to any third party .|
|Type:||C1 - Refereed Journal articles|
|Appears in Collections:||University of Sydney Research Outputs|
Items in Sydney Research Online are protected by copyright, with all rights reserved, unless otherwise indicated.